Evercore ISI cuts Albemarle stock rating, lowers PT to $88
Evercore ISI analyst Stephen Richardson downgraded Albemarle Corporation (NYSE:ALB) stock from Outperform to In Line, setting a new price target of $88.00. The company, currently valued at ...
bovnews4h
What’s Behind the 10.85% Gain in Mind Medicine (MindMed) Inc (MNMD) Stock? Find Out Now!
Mind Medicine (MindMed) Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of 0.74%. The profit margin, also known as the revenue ratio or gross profit ...
TipRanks on MSN6h
Albemarle downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Eric Boyes downgraded Albemarle (ALB) to In Line from Outperform with a price target of $88, down from $170. Published first ...